Interview: Reverse Split, Medmen, US Legalization with Tilray Brands CEO скачать в хорошем качестве

Interview: Reverse Split, Medmen, US Legalization with Tilray Brands CEO

Join us for an exclusive interview with Tilray Brands CEO Irwin Simon as he addresses critical investor concerns following Q3 2025 earnings and outlines Tilray’s bold strategies for growth in the cannabis, craft beer, and hemp beverage markets. From navigating Nasdaq listing challenges and dilution concerns to capitalizing on U.S. cannabis rescheduling and international expansion, this in-depth discussion covers it all! 🌿🍺 🔥 What You’ll Learn: How Tilray plans to restore investor confidence amid dilution and reverse split concerns post-Q3 2025 earnings miss. Strategies to regain Canadian market share and achieve global profitability in cannabis operations. Impact of U.S. Schedule 3 rescheduling on Tilray’s medical cannabis and Tilray USA entity plans. Expansion of hemp Delta-9 drinks, craft beer brands (SweetWater, Montauk, Blue Point), and potential brewpub ventures. Insights on M&A, Jones Soda/Mary Jones partnerships, and rumors of a Bain Capital takeover. Tilray’s innovative push into AI integration and crypto payments for e-commerce platforms. 💡 Why Watch? Get firsthand insights into Tilray’s diversified portfolio, ranked #4 among U.S. craft brewers, and its plans to dominate the global cannabis market (Canada, Germany, UK). Irwin discusses excise tax reform, Doordash/Total Wine distribution, and the future of cannabis beverages in bars and retail. Perfect for investors, cannabis enthusiasts, and craft beverage fans! 🔔 Subscribe for More! Stay ahead with the latest on cannabis legalization, craft beer trends, and investing in TLRY. Hit the subscribe button and turn on notifications 🔔 for daily updates! 📌 Links & Resources: Full Q3 2025 Earnings Report: https://ir.tilray.com/news-releases/n... Follow Tilray Brands: https://www.tilray.com/ Learn More About Hemp Drinks: https://drinkhappyflower.com/ 💬 Let’s Connect! What’s your take on Tilray’s strategy for U.S. legalization or hemp beverages? Drop a comment below—we’d love to hear from you! 🦅 Join this channel to get access to member-only YouTube videos and even more perks:    / @powgroup   🚨 NOT FINANCIAL ADVICE THIS IS FOR ENTERTAINMENT PURPOSES ONLY. 👕 POW Merch has launched! Visit www.powmerch.ca 🤖 POW Algo Alerts has launched! Visit https://pursuitofwealthgroup.com to learn more and find out about a free trial. 🎓 POW Group Academy has launched as well. Visit https://pursuitofwealthgroup.com and click on "Academy" link at the top of the page to enroll in our courses. ✨ Sponsors & The Essentials: Tangem Hardware Wallet 10% OFF: https://tangem.com/pricing/?promocode... WealthSimple: https://my.wealthsimple.com/app/publi... Uphold: https://uphold.sjv.io/POWGroup TradingView: https://www.tradingview.com/?offer_id... LinkTree (Social Links): https://linktr.ee/powgroup #TilrayBrands, #Interview, #IrwinSimon TIMESTAMPS 0:00 - Intro Host introduces Cannabis Insider, Tilray Brands, and CEO Irwin Simon; sets context for Q3 2025 earnings and key topics. 2:30 - Q3 2025 Earnings & Investor Concerns Irwin addresses missed Q3 2025 earnings estimates, why Tilray avoids lowering guidance, and the underpromise/overdeliver approach. 6:45 - Dilution & Executive Compensation Response to investor concerns about dilution post-reverse split, executive pay, and strategies like share buybacks or non-dilutive capital raises. 11:00 - Canadian Market Share & Profitability Strategies to regain market share in Canada, achieve global profitability, and projected timelines. 15:30 - Cannabis/Liquor Retail Plans Thoughts on entering cannabis/liquor retail in Canada, U.S., or abroad to address excise tax challenges. 19:00 - U.S. Craft Beer Success 22:15 - U.S. Cannabis Rescheduling Impact of potential Schedule 3 rescheduling on Tilray’s U.S. operations, medical cannabis sales, and insurance adjudication. 27:00 - Tilray USA & MedMen Strategy Plans for a Tilray USA entity, the logic behind MedMen investment (3 stores and IP), and post-legalization vision. 31:45 - U.S. Legalization Outlook Irwin’s expectations for U.S. cannabis legalization, banking reforms, and rescheduling under the new administration. 35:30 - Cross-Border Brand Expansion Plans to bring SweetWater, Montauk, Blue Point, or cannabis beverages to Canada/U.S., including tariff implications. 39:00 - Canadian Election & Excise Tax Reform Expectations for excise tax reform, sector hostility, or Health Canada changes (e.g., marketing, cannabis drinks in bars) post-election. 43:15 - International Growth (Germany, UK) Focus on Germany (79% flower sales growth), and Tilray’s top three international markets. 47:30 - Hemp Drinks & Brand Leverage 52:00 - Partnerships & M&A 57:00 - AI & Crypto Initiatives 1:01:00 - General Discussion / Q&A 1:03:30 - Outro